|
CA2472404A1
(en)
|
1993-07-19 |
1995-02-02 |
Angiotech Pharmaceuticals, Inc. |
Combination of stent and anti-angiogenic factor
|
|
US5886026A
(en)
*
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
US5443505A
(en)
*
|
1993-11-15 |
1995-08-22 |
Oculex Pharmaceuticals, Inc. |
Biocompatible ocular implants
|
|
US5620013A
(en)
*
|
1994-10-21 |
1997-04-15 |
American Cyanamid Company |
Method for destroying residual lens epithelial cells
|
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US6299895B1
(en)
|
1997-03-24 |
2001-10-09 |
Neurotech S.A. |
Device and method for treating ophthalmic diseases
|
|
US5904144A
(en)
*
|
1996-03-22 |
1999-05-18 |
Cytotherapeutics, Inc. |
Method for treating ophthalmic diseases
|
|
US6063370A
(en)
*
|
1996-04-05 |
2000-05-16 |
The Board Of Trustees Of The University Of Illinois |
Macromolecular complexes for drug delivery
|
|
US5935599A
(en)
*
|
1996-10-28 |
1999-08-10 |
The Board Of Trustees Of The University Of Illinois |
Polymer-associated liposomes for drug delivery and method of manufacturing the same
|
|
JP2001513369A
(ja)
*
|
1997-08-11 |
2001-09-04 |
アラーガン・セイルズ・インコーポレイテッド |
改善された生物適合性を有する無菌の生物侵食性の移植デバイスおよび方法
|
|
US6007578A
(en)
*
|
1997-10-08 |
1999-12-28 |
Ras Holding Corp |
Scleral prosthesis for treatment of presbyopia and other eye disorders
|
|
US6991650B2
(en)
|
1997-10-08 |
2006-01-31 |
Refocus Ocular, Inc. |
Scleral expansion device having duck bill
|
|
RU2120254C1
(ru)
*
|
1997-10-28 |
1998-10-20 |
Институт нефтехимического синтеза им.А.В.Топчиева РАН |
Имплантат для реконструктивно-восстановительной хирургии
|
|
RU2119780C1
(ru)
*
|
1997-10-28 |
1998-10-10 |
Институт нефтехимического синтеза им.А.В.Топчиева РАН |
Имплантат для реконструктивно-восстановительной хирургии
|
|
WO1999055396A1
(en)
|
1998-04-27 |
1999-11-04 |
Surmodics, Inc. |
Bioactive agent release coating
|
|
AU4847999A
(en)
*
|
1998-06-29 |
2000-01-17 |
George W. Rozakis |
Antioxidant intraocular lens
|
|
US6024719A
(en)
|
1998-07-06 |
2000-02-15 |
Morris; Robert E |
Method and apparatus for performing surgery inside the human retina using fluidic internal limiting membrane (ILM) seperation (FILMS)
|
|
US6378526B1
(en)
|
1998-08-03 |
2002-04-30 |
Insite Vision, Incorporated |
Methods of ophthalmic administration
|
|
US6309374B1
(en)
|
1998-08-03 |
2001-10-30 |
Insite Vision Incorporated |
Injection apparatus and method of using same
|
|
FR2787991B1
(fr)
*
|
1998-12-31 |
2001-05-25 |
Medicale De Prec S M P Sa Soc |
Dispositif pour traiter la presbytie ou autre affection oculaire
|
|
EP1154691A4
(de)
*
|
1999-01-05 |
2004-07-07 |
Massachusetts Eye & Ear Infirm |
Gezielte transsklerale gesteuerte wirkstoffabgabe an die retina und choroidae
|
|
US6113638A
(en)
*
|
1999-02-26 |
2000-09-05 |
Williams; Lytton A. |
Method and apparatus for intervertebral implant anchorage
|
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US6464724B1
(en)
|
1999-04-26 |
2002-10-15 |
Gmp Vision Solutions, Inc. |
Stent device and method for treating glaucoma
|
|
US6699210B2
(en)
*
|
1999-04-27 |
2004-03-02 |
The Arizona Board Of Regents |
Glaucoma shunt and a method of making and surgically implanting the same
|
|
TW587934B
(en)
|
1999-06-07 |
2004-05-21 |
Ronald A Schachar |
Improved scleral prosthesis for the treatment of presbyopia and other eye disorders
|
|
US7008396B1
(en)
|
1999-09-03 |
2006-03-07 |
Restorvision, Inc. |
Ophthalmic device and method of manufacture and use
|
|
DE19947711B4
(de)
*
|
1999-10-04 |
2004-02-12 |
Schrage, Norbert, Priv. Doz. Dr.med. |
Implantat zum Eisatz in der Glaukomtherapie
|
|
JP2003511204A
(ja)
|
1999-10-21 |
2003-03-25 |
アルコン，インコーポレイティド |
テノン下薬剤送出
|
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
|
CA2383499C
(en)
*
|
1999-10-21 |
2009-11-24 |
Alcon Universal Ltd. |
Drug delivery device
|
|
US6331313B1
(en)
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US6852688B2
(en)
|
2000-03-10 |
2005-02-08 |
University Of Florida |
Compositions for treating diabetic retinopathy and methods of using same
|
|
US6638239B1
(en)
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
|
US20050049578A1
(en)
*
|
2000-04-14 |
2005-03-03 |
Hosheng Tu |
Implantable ocular pump to reduce intraocular pressure
|
|
US20020143284A1
(en)
*
|
2001-04-03 |
2002-10-03 |
Hosheng Tu |
Drug-releasing trabecular implant for glaucoma treatment
|
|
US20040111050A1
(en)
*
|
2000-04-14 |
2004-06-10 |
Gregory Smedley |
Implantable ocular pump to reduce intraocular pressure
|
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
|
US20050277864A1
(en)
*
|
2000-04-14 |
2005-12-15 |
David Haffner |
Injectable gel implant for glaucoma treatment
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US6417237B1
(en)
|
2000-06-08 |
2002-07-09 |
The Board Of Trustees Of The University Of Illinois |
Macromolecular drug complexes and compositions containing the same
|
|
US6692759B1
(en)
*
|
2000-06-28 |
2004-02-17 |
The Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
EP1637126B1
(de)
*
|
2000-07-05 |
2016-12-14 |
Allergan, Inc. |
Verfahren zur Behandlung von entzündungsbedingten Zuständen der Augen
|
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
|
DE60135352D1
(de)
*
|
2000-08-30 |
2008-09-25 |
Univ Johns Hopkins |
Vorrichtung zur intraokularen wirkstoffverabreichung
|
|
PE20020578A1
(es)
|
2000-10-10 |
2002-08-14 |
Upjohn Co |
Una composicion de antibiotico topico para el tratamiento de infecciones oculares
|
|
WO2002058730A2
(en)
*
|
2000-11-01 |
2002-08-01 |
Allergan, Inc. |
Compositions for treatment of ocular neovascularization
|
|
US20030082183A1
(en)
*
|
2000-11-01 |
2003-05-01 |
Wheeler Larry A. |
Methods and compositions for treatment of ocular neovascularization and neural injury
|
|
US6534693B2
(en)
*
|
2000-11-06 |
2003-03-18 |
Afmedica, Inc. |
Surgically implanted devices having reduced scar tissue formation
|
|
EP1339438B1
(de)
|
2000-11-29 |
2005-10-19 |
Allergan Inc. |
Verhinderung von transplantatabstossung im auge
|
|
WO2002055058A2
(en)
*
|
2001-01-09 |
2002-07-18 |
Microchips, Inc. |
Flexible microchip devices for ophthalmic and other applications
|
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
|
US6981958B1
(en)
*
|
2001-05-02 |
2006-01-03 |
Glaukos Corporation |
Implant with pressure sensor for glaucoma treatment
|
|
WO2002080811A2
(en)
|
2001-04-07 |
2002-10-17 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
US7488303B1
(en)
*
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
|
US7795218B2
(en)
|
2001-04-12 |
2010-09-14 |
Bioaxone Therapeutique Inc. |
ADP-ribosyl transferase fusion variant proteins
|
|
US20040022853A1
(en)
*
|
2001-04-26 |
2004-02-05 |
Control Delivery Systems, Inc. |
Polymer-based, sustained release drug delivery system
|
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
|
US7094225B2
(en)
|
2001-05-03 |
2006-08-22 |
Glaukos Corporation |
Medical device and methods of use of glaucoma treatment
|
|
EP1387671A1
(de)
|
2001-05-03 |
2004-02-11 |
MASSACHUSETTS EYE & EAR INFIRMARY |
Implantierbare arzneistoffverabreichungsvorrichtung und verwendung derselben
|
|
US20060241750A1
(en)
*
|
2001-05-22 |
2006-10-26 |
Ras Holding Corp |
Scleral expansion device having duck bill
|
|
EP1404297B1
(de)
|
2001-06-12 |
2011-04-27 |
The Johns Hopkins University School Of Medicine |
Reservoirvorrichtung für die intraokulare arzneimittelabgabe
|
|
US7592016B2
(en)
*
|
2001-06-28 |
2009-09-22 |
Regents Of The University Of California |
Methods for preparing and using implantable substance delivery devices
|
|
DE10133870A1
(de)
*
|
2001-07-12 |
2003-02-06 |
Chris P Lohmann |
Ophthalmisches Mittel, Verwendung von EGF zur Behandlung von Dry Eye-Syndrom und Insert zur Verabreichung von EGF am Auge
|
|
WO2003009774A2
(en)
|
2001-07-23 |
2003-02-06 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
|
AU2002319606B2
(en)
*
|
2001-07-23 |
2006-09-14 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
|
US8267995B2
(en)
*
|
2001-08-03 |
2012-09-18 |
David Castillejos |
Method and intra sclera implant for treatment of glaucoma and presbyopia
|
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
|
WO2003020172A1
(en)
*
|
2001-08-29 |
2003-03-13 |
De Carvalho Ricardo A P |
An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
|
|
GB0122318D0
(en)
*
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
|
IN2014DN10834A
(de)
*
|
2001-09-17 |
2015-09-04 |
Psivida Inc |
|
|
EP1455689B1
(de)
*
|
2001-10-30 |
2007-02-21 |
Eyeborn (Proprietary) Limited |
Orbitalimplantat
|
|
FR2833493B1
(fr)
*
|
2001-12-18 |
2005-09-23 |
Ioltechnologie Production |
Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
|
|
US20030180294A1
(en)
*
|
2002-02-22 |
2003-09-25 |
Devries Gerald W. |
Methods of extending corneal graft survival
|
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
|
KR101173497B1
(ko)
*
|
2002-03-11 |
2012-08-14 |
알콘, 인코퍼레이티드 |
이식 가능한 약물 전달 시스템
|
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
|
US20040147870A1
(en)
*
|
2002-04-08 |
2004-07-29 |
Burns Thomas W. |
Glaucoma treatment kit
|
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
|
US20040024345A1
(en)
*
|
2002-04-19 |
2004-02-05 |
Morteza Gharib |
Glaucoma implant with valveless flow bias
|
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
BR0309844A
(pt)
*
|
2002-05-07 |
2005-02-15 |
Control Delivery Sys Inc |
Processos para formação de um dispositivo para a distribuição de droga
|
|
US7097850B2
(en)
*
|
2002-06-18 |
2006-08-29 |
Surmodics, Inc. |
Bioactive agent release coating and controlled humidity method
|
|
ES2277087T3
(es)
*
|
2002-07-09 |
2007-07-01 |
Aecc Enterprises Limited |
Metodo para representacion con imagenes el movimiento relativo de segmentos esqueleticos.
|
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
|
ES2295647T3
(es)
*
|
2002-07-15 |
2008-04-16 |
Alcon, Inc. |
Composiciones de implante farmaceuticas lipofilas, no polimeras, para uso intraocular.
|
|
US20070027537A1
(en)
*
|
2002-08-02 |
2007-02-01 |
David Castillejos |
Method and intra-sclera implant for treatment of glaucoma and presbyopia
|
|
WO2004026347A2
(en)
*
|
2002-09-17 |
2004-04-01 |
Iscience Surgical Corporation |
Apparatus and method for surgical bypass of aqueous humor
|
|
CN1301692C
(zh)
|
2002-09-18 |
2007-02-28 |
阿勒根公司 |
眼植入物导入的器械
|
|
US7468065B2
(en)
|
2002-09-18 |
2008-12-23 |
Allergan, Inc. |
Apparatus for delivery of ocular implants
|
|
US20050203542A1
(en)
*
|
2002-09-18 |
2005-09-15 |
Allergan, Inc. |
Apparatus for delivery of ocular implants with reduced incidence of ocular adverse events
|
|
US6899717B2
(en)
*
|
2002-09-18 |
2005-05-31 |
Allergan, Inc. |
Methods and apparatus for delivery of ocular implants
|
|
AU2003301347A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Control Delivery Systems, Inc. |
Methods for monitoring treatment of disease
|
|
US20040111144A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Lawin Laurie R. |
Barriers for polymeric coatings
|
|
WO2004056806A1
(en)
*
|
2002-12-19 |
2004-07-08 |
Pfizer Inc. |
2-(1h-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophtalmic diseases
|
|
US20060166879A1
(en)
*
|
2002-12-20 |
2006-07-27 |
Chakshu Research Inc |
Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
|
|
NZ540885A
(en)
*
|
2002-12-20 |
2009-02-28 |
Chakshu Res Inc |
Ophthalmic formulation for the prevention and treatment of ocular conditions
|
|
US20060177430A1
(en)
*
|
2002-12-20 |
2006-08-10 |
Chakshu Research Inc |
Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
|
|
US20060172972A1
(en)
*
|
2002-12-20 |
2006-08-03 |
Chakshu Research Inc |
Formulation and method for administration of ophthalmologically active agents
|
|
US8185209B2
(en)
*
|
2003-01-03 |
2012-05-22 |
Board Of Trustees Operating Michigan State University |
Methods to extend vision to infrared wavelengths
|
|
US20040137059A1
(en)
|
2003-01-09 |
2004-07-15 |
Thierry Nivaggioli |
Biodegradable ocular implant
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
US20060167435A1
(en)
*
|
2003-02-18 |
2006-07-27 |
Adamis Anthony P |
Transscleral drug delivery device and related methods
|
|
US9216106B2
(en)
|
2003-04-09 |
2015-12-22 |
Directcontact Llc |
Device and method for the delivery of drugs for the treatment of posterior segment disease
|
|
CA2524271C
(en)
*
|
2003-05-02 |
2012-09-04 |
Surmodics, Inc. |
Controlled release bioactive agent delivery device
|
|
US8246974B2
(en)
|
2003-05-02 |
2012-08-21 |
Surmodics, Inc. |
Medical devices and methods for producing the same
|
|
US20040225250A1
(en)
|
2003-05-05 |
2004-11-11 |
Michael Yablonski |
Internal shunt and method for treating glaucoma
|
|
US7589107B2
(en)
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
|
US20050009910A1
(en)
*
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
|
KR20060082792A
(ko)
*
|
2003-07-10 |
2006-07-19 |
알콘, 인코퍼레이티드 |
안과용 약물 전달 장치
|
|
WO2005012537A2
(en)
*
|
2003-07-25 |
2005-02-10 |
Genvec, Inc. |
Adenoviral vector-based vaccines
|
|
KR20060085246A
(ko)
|
2003-09-18 |
2006-07-26 |
마커사이트, 인코포레이티드 |
경공막 전달
|
|
US20050101582A1
(en)
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
|
WO2005048873A2
(en)
*
|
2003-11-12 |
2005-06-02 |
Alcon, Inc. |
Kit for administration of a drug
|
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
|
NZ575950A
(en)
*
|
2003-11-13 |
2010-06-25 |
Psivida Inc |
Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin
|
|
US7291125B2
(en)
|
2003-11-14 |
2007-11-06 |
Transcend Medical, Inc. |
Ocular pressure regulation
|
|
DE602004025726D1
(de)
*
|
2003-11-14 |
2010-04-08 |
Genvec Inc |
Pharmazeutische verbindung zur behandlung von lokal fortgeschrittenem primär inoperablen pankreaskarzinom (lapc).
|
|
CA2546042A1
(en)
|
2003-11-20 |
2005-06-09 |
Othera Pharmaceuticals, Inc. |
Amelioration of macular degeneration and other ophthalmic diseases
|
|
EP1711196A4
(de)
|
2003-12-05 |
2011-09-14 |
Bristol Myers Squibb Co |
Inhibitoren von typ-2 vaskulären endothelialen wachstumsfaktor-rezeptoren
|
|
US20080220049A1
(en)
*
|
2003-12-05 |
2008-09-11 |
Adnexus, A Bristol-Myers Squibb R&D Company |
Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins
|
|
US7211272B2
(en)
*
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
DE602005011928D1
(de)
|
2004-01-20 |
2009-02-05 |
Allergan Inc |
Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
|
|
US20050250788A1
(en)
*
|
2004-01-30 |
2005-11-10 |
Hosheng Tu |
Aqueous outflow enhancement with vasodilated aqueous cavity
|
|
JP2007532187A
(ja)
|
2004-04-06 |
2007-11-15 |
サーモディクス，インコーポレイティド |
生物活性物質のためのコーティング組成物
|
|
AU2005243730B2
(en)
|
2004-04-12 |
2010-05-27 |
Genvec, Inc. |
Method of using adenoviral vectors to induce an immune response
|
|
US7691381B2
(en)
*
|
2004-04-15 |
2010-04-06 |
Allergan, Inc. |
Stabilized biodegradable neurotoxin implants
|
|
US20050232972A1
(en)
|
2004-04-15 |
2005-10-20 |
Steven Odrich |
Drug delivery via punctal plug
|
|
WO2005105133A2
(en)
*
|
2004-04-23 |
2005-11-10 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
|
US20080058704A1
(en)
*
|
2004-04-29 |
2008-03-06 |
Michael Hee |
Apparatus and Method for Ocular Treatment
|
|
MXPA06012460A
(es)
*
|
2004-04-29 |
2007-07-13 |
Iscience Surgical Corp |
Metodo y aparato para mejora quirurgica de drenaje de humor acuoso.
|
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
|
US8685435B2
(en)
*
|
2004-04-30 |
2014-04-01 |
Allergan, Inc. |
Extended release biodegradable ocular implants
|
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
|
US20060182783A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems
|
|
WO2005107708A1
(en)
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase inhibitors implants
|
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
|
WO2005110374A1
(en)
|
2004-04-30 |
2005-11-24 |
Allergan, Inc. |
Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
|
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
|
US7771742B2
(en)
*
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
|
US20070212395A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Allergan, Inc. |
Ocular therapy using sirtuin-activating agents
|
|
AU2011213904B2
(en)
*
|
2004-04-30 |
2014-06-05 |
Allergan, Inc. |
Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies
|
|
US8673341B2
(en)
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US8529927B2
(en)
*
|
2004-04-30 |
2013-09-10 |
Allergan, Inc. |
Alpha-2 agonist polymeric drug delivery systems
|
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US20050244500A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intravitreal implants in conjuction with photodynamic therapy to improve vision
|
|
CA2572223C
(en)
|
2004-06-25 |
2014-08-12 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
|
WO2006014484A2
(en)
*
|
2004-07-02 |
2006-02-09 |
Surmodics, Inc. |
Methods and devices for the treatment of ocular conditions
|
|
US7922702B2
(en)
|
2004-07-02 |
2011-04-12 |
Qlt Inc. |
Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device
|
|
WO2006017347A2
(en)
*
|
2004-07-12 |
2006-02-16 |
Allergan, Inc. |
Opthalmic compositions and methods for treating ophthalmic conditions
|
|
AU2005274948B2
(en)
|
2004-07-16 |
2011-09-22 |
Genvec, Inc. |
Vaccines against aids comprising CMV/R-nucleic acid constructs
|
|
US7117870B2
(en)
*
|
2004-07-26 |
2006-10-10 |
Clarity Corporation |
Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
|
|
WO2006078320A2
(en)
|
2004-08-04 |
2006-07-27 |
Brookwood Pharmaceuticals, Inc. |
Methods for manufacturing delivery devices and devices thereof
|
|
US7722669B2
(en)
|
2004-08-13 |
2010-05-25 |
Richard Foulkes |
Method and insert for modifying eye color
|
|
US8246569B1
(en)
|
2004-08-17 |
2012-08-21 |
California Institute Of Technology |
Implantable intraocular pressure drain
|
|
US20060047250A1
(en)
*
|
2004-08-30 |
2006-03-02 |
Hickingbotham Dyson W |
Fluid delivery device
|
|
EP1784493A2
(de)
*
|
2004-09-01 |
2007-05-16 |
The Government of the United States of America as Represented by The Department of Health and Human Services |
Adenovirale vektoren mit der fähigkeit zum umwandeln von apcs, mögliche verwendung bei immunantworterzeugung
|
|
CN100428958C
(zh)
*
|
2004-09-06 |
2008-10-29 |
段亚东 |
一种治疗眼病的植入剂
|
|
KR101341359B1
(ko)
|
2004-10-01 |
2013-12-13 |
램스코르 인코포레이티드 |
편리하게 이식가능한 서방형 약물 조성물
|
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US8541413B2
(en)
*
|
2004-10-01 |
2013-09-24 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
WO2006043965A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
|
US7226435B2
(en)
*
|
2004-10-14 |
2007-06-05 |
Alcon, Inc. |
Drug delivery device
|
|
US8246949B2
(en)
*
|
2004-10-27 |
2012-08-21 |
Aciont, Inc. |
Methods and devices for sustained in-vivo release of an active agent
|
|
US20060107555A1
(en)
*
|
2004-11-09 |
2006-05-25 |
Curtis Marc D |
Universal snow plow adapter
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
DK1848431T3
(en)
|
2005-02-09 |
2016-04-18 |
Santen Pharmaceutical Co Ltd |
LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
|
|
US7699863B2
(en)
*
|
2005-03-01 |
2010-04-20 |
Tulip Medical Ltd. |
Bioerodible self-deployable intragastric implants
|
|
US7785291B2
(en)
*
|
2005-03-01 |
2010-08-31 |
Tulip Medical Ltd. |
Bioerodible self-deployable intragastric implants
|
|
US20060204548A1
(en)
*
|
2005-03-01 |
2006-09-14 |
Allergan, Inc. |
Microimplants for ocular administration
|
|
US20060233858A1
(en)
*
|
2005-03-08 |
2006-10-19 |
Allergan, Inc. |
Systems and methods providing targeted intraocular drug delivery
|
|
US7759312B2
(en)
*
|
2005-03-11 |
2010-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Delivery of dry formulations of octreotide
|
|
CN101193626A
(zh)
*
|
2005-03-11 |
2008-06-04 |
益德威士医药股份有限公司 |
奥曲肽的受控释放制剂
|
|
AU2006227116A1
(en)
*
|
2005-03-21 |
2006-09-28 |
Santen Pharmaceutical Co., Ltd. |
Drug delivery systems for treatment of diseases or conditions
|
|
US7931909B2
(en)
*
|
2005-05-10 |
2011-04-26 |
Allergan, Inc. |
Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
|
|
US20060258994A1
(en)
*
|
2005-05-12 |
2006-11-16 |
Avery Robert L |
Implantable delivery device for administering pharmacological agents to an internal portion of a body
|
|
US20080312283A1
(en)
*
|
2005-05-26 |
2008-12-18 |
Othera Pharmaceuticals, Inc. |
Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts
|
|
US20070021762A1
(en)
*
|
2005-07-13 |
2007-01-25 |
Qing Liu |
Ocular plug formed from placenta derived collagen biofabric
|
|
CN101262887A
(zh)
*
|
2005-07-15 |
2008-09-10 |
视可舒研究公司 |
糖尿病的眼科并发症的预防和治疗
|
|
US20100004156A1
(en)
|
2005-07-27 |
2010-01-07 |
Shalesh Kaushal |
Small Compounds That Correct Protein Misfolding and Uses Thereof
|
|
US7592330B2
(en)
*
|
2005-08-08 |
2009-09-22 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
|
US20070060887A1
(en)
*
|
2005-08-22 |
2007-03-15 |
Marsh David A |
Ophthalmic injector
|
|
BRPI0615400A2
(pt)
*
|
2005-08-31 |
2011-05-17 |
Genvec Inc |
vacinas para malária baseadas em vetor adenoviral
|
|
CA2850858A1
(en)
*
|
2005-09-16 |
2007-04-05 |
Allergan, Inc. |
Compositions and methods for the intraocular transport of therapeutic agents
|
|
US8168584B2
(en)
|
2005-10-08 |
2012-05-01 |
Potentia Pharmaceuticals, Inc. |
Methods of treating age-related macular degeneration by compstatin and analogs thereof
|
|
MX339797B
(es)
*
|
2005-10-18 |
2016-06-10 |
Allergan Inc |
Terapia ocular que usa derivados glucocorticoides que penetran selectivamente los tejidos del segmento posterior.
|
|
US9067047B2
(en)
*
|
2005-11-09 |
2015-06-30 |
The Invention Science Fund I, Llc |
Injectable controlled release fluid delivery system
|
|
BRPI0618441B8
(pt)
*
|
2005-11-10 |
2021-07-27 |
Genvec Inc |
vetor adenoviral
|
|
EA016227B1
(ru)
|
2005-11-29 |
2012-03-30 |
Смитклайн Бичем Корпорейшн |
Способ лечения офтальмологических неоваскулярных расстройств
|
|
EP1978892B1
(de)
*
|
2006-01-17 |
2017-11-15 |
Novartis Ag |
Behandlungsvorrichtung zur wirkstofffreisetzung
|
|
EP1979023B1
(de)
|
2006-01-17 |
2015-07-22 |
Transcend Medical, Inc. |
Glaukombehandlungsvorrichtung
|
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
|
JP2009531283A
(ja)
|
2006-02-02 |
2009-09-03 |
アラーガン、インコーポレイテッド |
眼系疾患の処置のための組成物および方法
|
|
KR20140093764A
(ko)
|
2006-02-09 |
2014-07-28 |
산텐 세이야꾸 가부시키가이샤 |
안정한 제제와 그 제조 및 사용 방법
|
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
|
US20070202186A1
(en)
|
2006-02-22 |
2007-08-30 |
Iscience Interventional Corporation |
Apparatus and formulations for suprachoroidal drug delivery
|
|
US20080140057A1
(en)
*
|
2006-03-09 |
2008-06-12 |
Searete Llc, A Limited Liability Corporation Of State Of The Delaware |
Injectable controlled release fluid delivery system
|
|
EP2319558B1
(de)
|
2006-03-14 |
2014-05-21 |
University Of Southern California |
Mems-Vorrichtung zur Wirkstofffreisetzung
|
|
ES2563288T3
(es)
|
2006-03-23 |
2016-03-14 |
Santen Pharmaceutical Co., Ltd |
Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
|
|
SG170816A1
(en)
|
2006-03-31 |
2011-05-30 |
Qlt Plug Delivery Inc |
Drug delivery methods, structures, and compositions for nasolacrimal system
|
|
US8676293B2
(en)
*
|
2006-04-13 |
2014-03-18 |
Aecc Enterprises Ltd. |
Devices, systems and methods for measuring and evaluating the motion and function of joint structures and associated muscles, determining suitability for orthopedic intervention, and evaluating efficacy of orthopedic intervention
|
|
US20070293807A1
(en)
*
|
2006-05-01 |
2007-12-20 |
Lynch Mary G |
Dual drainage pathway shunt device and method for treating glaucoma
|
|
US20070260203A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Allergan, Inc. |
Vasoactive agent intraocular implant
|
|
US7862540B2
(en)
*
|
2006-05-17 |
2011-01-04 |
Alcon Research, Ltd. |
Ophthalmic injection device using shape memory alloy
|
|
US7674243B2
(en)
*
|
2006-05-17 |
2010-03-09 |
Alcon Inc. |
Ophthalmic injection device using piezoelectric array
|
|
US20070270750A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Alcon, Inc. |
Drug delivery device
|
|
US7887521B2
(en)
*
|
2006-05-17 |
2011-02-15 |
Alcon Research, Ltd. |
Ophthalmic injection system
|
|
US7871399B2
(en)
*
|
2006-05-17 |
2011-01-18 |
Alcon Research, Ltd. |
Disposable ophthalmic injection device
|
|
US20070268340A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Ophthalmic Injection System and Method Using Piezoelectric Array
|
|
US20070270768A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Bruno Dacquay |
Mechanical Linkage Mechanism For Ophthalmic Injection Device
|
|
US7811252B2
(en)
*
|
2006-05-17 |
2010-10-12 |
Alcon Research, Ltd. |
Dosage control device
|
|
US8668676B2
(en)
*
|
2006-06-19 |
2014-03-11 |
Allergan, Inc. |
Apparatus and methods for implanting particulate ocular implants
|
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US20120123316A1
(en)
|
2010-11-15 |
2012-05-17 |
Aquesys, Inc. |
Intraocular shunts for placement in the intra-tenon's space
|
|
US9095411B2
(en)
|
2010-11-15 |
2015-08-04 |
Aquesys, Inc. |
Devices for deploying intraocular shunts
|
|
US8663303B2
(en)
|
2010-11-15 |
2014-03-04 |
Aquesys, Inc. |
Methods for deploying an intraocular shunt from a deployment device and into an eye
|
|
AU2007269259B2
(en)
|
2006-06-30 |
2012-05-31 |
Aquesys Inc. |
Methods, systems and apparatus for relieving pressure in an organ
|
|
US10085884B2
(en)
|
2006-06-30 |
2018-10-02 |
Aquesys, Inc. |
Intraocular devices
|
|
US8721702B2
(en)
|
2010-11-15 |
2014-05-13 |
Aquesys, Inc. |
Intraocular shunt deployment devices
|
|
US8308701B2
(en)
|
2010-11-15 |
2012-11-13 |
Aquesys, Inc. |
Methods for deploying intraocular shunts
|
|
US8852256B2
(en)
|
2010-11-15 |
2014-10-07 |
Aquesys, Inc. |
Methods for intraocular shunt placement
|
|
US8911496B2
(en)
|
2006-07-11 |
2014-12-16 |
Refocus Group, Inc. |
Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
|
|
MX2009000378A
(es)
|
2006-07-11 |
2009-08-12 |
Refocus Group Inc |
Protesis escleral para tratar presbiopia y otros trastornos del ojo y dispositivos y metodos relacionados.
|
|
US9039761B2
(en)
*
|
2006-08-04 |
2015-05-26 |
Allergan, Inc. |
Ocular implant delivery assemblies with distal caps
|
|
EP2617424A3
(de)
|
2006-08-23 |
2014-05-07 |
Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
Harn- und Thioharnsäurederivate für Erkrankungen in Verbindung mit oxidativem Stress
|
|
US20100241046A1
(en)
*
|
2006-09-06 |
2010-09-23 |
Innfocus, Llc |
Apparatus, methods and devices for treatment of ocular disorders
|
|
US20080097379A1
(en)
*
|
2006-09-26 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection method
|
|
US20080125712A1
(en)
*
|
2006-09-26 |
2008-05-29 |
Alcon Manufacturing, Ltd. |
Ophthalmic injection system
|
|
US20080097390A1
(en)
*
|
2006-09-27 |
2008-04-24 |
Alcon Manufacturing, Ltd. |
Spring actuated delivery system
|
|
EP2068828A2
(de)
*
|
2006-09-29 |
2009-06-17 |
SurModics, Inc. |
Biologisch abbaubare augenimplantate und verfahren zur behandlung von augenleiden
|
|
US20080091178A1
(en)
*
|
2006-10-11 |
2008-04-17 |
Sunalp Murad A |
Device and method for medical records storage in the eye
|
|
AU2007347736A1
(en)
*
|
2006-10-16 |
2008-09-04 |
Alcon Research, Ltd. |
Universal rechargeable limited reuse assembly for ophthalmic hand piece
|
|
US9022970B2
(en)
*
|
2006-10-16 |
2015-05-05 |
Alcon Research, Ltd. |
Ophthalmic injection device including dosage control device
|
|
JP2010506671A
(ja)
*
|
2006-10-16 |
2010-03-04 |
アルコン リサーチ， リミテッド |
使い捨て端部を持つ眼科用ハンドピースの作動方法
|
|
US20080281292A1
(en)
*
|
2006-10-16 |
2008-11-13 |
Hickingbotham Dyson W |
Retractable Injection Port
|
|
US8586556B2
(en)
|
2006-11-03 |
2013-11-19 |
Allergan, Inc. |
Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
|
|
US8039010B2
(en)
|
2006-11-03 |
2011-10-18 |
Allergan, Inc. |
Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier
|
|
WO2008061043A2
(en)
|
2006-11-10 |
2008-05-22 |
Glaukos Corporation |
Uveoscleral shunt and methods for implanting same
|
|
WO2008063639A2
(en)
|
2006-11-21 |
2008-05-29 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for preserving cells of the eye
|
|
MX2009005466A
(es)
|
2006-11-22 |
2009-08-17 |
Adnexus A Bristol Myers Sqibb |
Terapeuticos dirigidos a base de proteinas manipuladas para receptores de tirosina cinasas, incluyendo receptor de factor de crecimiento tipo insulina-i.
|
|
EP2091482A2
(de)
|
2006-12-01 |
2009-08-26 |
Allergan, Inc. |
Verfahren zur bestimmung optimaler intraokularer standorte für systeme zur verabreichung von medikamenten
|
|
US8969415B2
(en)
*
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
|
WO2008073576A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Alcon, Inc. |
Drug delivery device
|
|
US8846073B2
(en)
*
|
2006-12-19 |
2014-09-30 |
Allergan, Inc. |
Low temperature processes for making cyclic lipid implants for intraocular use
|
|
US20090092574A1
(en)
|
2006-12-29 |
2009-04-09 |
Scott Richard W |
Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
|
|
US20080248060A1
(en)
*
|
2007-01-09 |
2008-10-09 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
|
JP4957258B2
(ja)
*
|
2007-01-15 |
2012-06-20 |
富士通株式会社 |
歩数計数装置および歩数計数方法
|
|
GB0713463D0
(en)
|
2007-07-11 |
2007-08-22 |
Btg Int Ltd |
Modulators of hypoxia inducible factor-1 and related uses
|
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
|
US8231892B2
(en)
*
|
2007-05-24 |
2012-07-31 |
Allergan, Inc. |
Biodegradable drug delivery system
|
|
US8492334B2
(en)
*
|
2007-06-21 |
2013-07-23 |
Yale University |
Sustained intraocular delivery of drugs from biodegradable polymeric microparticles
|
|
US20090018548A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Intraocular Lens Injection Device with Removable Cartridge
|
|
US20090018512A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Charles Steven T |
Pneumatically-Powered Ophthalmic Injector
|
|
WO2009012406A1
(en)
|
2007-07-17 |
2009-01-22 |
Transcend Medical, Inc. |
Ocular implant with hydrogel expansion capabilities reference to priority document
|
|
US8968396B2
(en)
|
2007-07-23 |
2015-03-03 |
Powervision, Inc. |
Intraocular lens delivery systems and methods of use
|
|
US7740619B2
(en)
*
|
2007-08-01 |
2010-06-22 |
Alcon Research, Ltd. |
Spring driven ophthalmic injection device with safety actuator lockout feature
|
|
JP5323073B2
(ja)
*
|
2007-08-02 |
2013-10-23 |
リフォーカス グループ、インコーポレイテッド |
老眼及び他の眼疾患を治療するためのクロスバーを有する強膜プロテーゼ
|
|
US20090036842A1
(en)
*
|
2007-08-03 |
2009-02-05 |
Raffi Pinedjian |
Consumable Activation Lever For Injection Device
|
|
US7629768B2
(en)
*
|
2007-08-03 |
2009-12-08 |
Alcon Research, Ltd. |
Easy cleaning C-shaped charging base
|
|
US9011361B2
(en)
|
2007-09-07 |
2015-04-21 |
Mati Therapeutics Inc. |
Lacrimal implant detection
|
|
TWI498136B
(zh)
*
|
2007-10-09 |
2015-09-01 |
Alcon Res Ltd |
用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
|
|
TWI451862B
(zh)
*
|
2007-10-09 |
2014-09-11 |
Alcon Res Ltd |
用於眼睛注射的熱係數驅動藥丸尺寸
|
|
US20090099481A1
(en)
|
2007-10-10 |
2009-04-16 |
Adam Deitz |
Devices, Systems and Methods for Measuring and Evaluating the Motion and Function of Joints and Associated Muscles
|
|
EP2214608B1
(de)
|
2007-11-08 |
2015-03-04 |
Alimera Sciences, Inc. |
Okulare implantationsvorrichtung
|
|
WO2009085952A1
(en)
|
2007-12-20 |
2009-07-09 |
Brookwood Pharmaceuticals, Inc. |
Process for preparing microparticles having a low residual solvent volume
|
|
JP5542691B2
(ja)
|
2007-12-20 |
2014-07-09 |
ユニバーシティ オブ サザン カリフォルニア |
治療薬を送達するための装置および方法
|
|
US20090162417A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Cook Incorporated |
Drug eluting ocular conformer
|
|
ES2577502T3
(es)
|
2008-01-03 |
2016-07-15 |
University Of Southern California |
Dispositivos implantables de administración de fármacos y aparato para recargar los dispositivos
|
|
US8602959B1
(en)
*
|
2010-05-21 |
2013-12-10 |
Robert Park |
Methods and devices for delivery of radiation to the posterior portion of the eye
|
|
AU2009213141A1
(en)
|
2008-02-14 |
2009-08-20 |
Bristol-Myers Squibb Company |
Targeted therapeutics based on engineered proteins that bind EGFR
|
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
|
US20090227938A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Insitu Therapeutics, Inc. |
Wound Closure Devices, Methods of Use, and Kits
|
|
EP2320989B1
(de)
*
|
2008-05-08 |
2015-03-11 |
MiniPumps, LLC |
Implantierbare pumpen und kanülen dafür
|
|
US8231608B2
(en)
*
|
2008-05-08 |
2012-07-31 |
Minipumps, Llc |
Drug-delivery pumps and methods of manufacture
|
|
CN102202706A
(zh)
|
2008-05-08 |
2011-09-28 |
迷你泵有限责任公司 |
可植入药物传送装置与用于填充该装置的设备和方法
|
|
US9333297B2
(en)
|
2008-05-08 |
2016-05-10 |
Minipumps, Llc |
Drug-delivery pump with intelligent control
|
|
AU2009246520B2
(en)
|
2008-05-12 |
2012-04-19 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
US9877973B2
(en)
|
2008-05-12 |
2018-01-30 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
US9095404B2
(en)
|
2008-05-12 |
2015-08-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
US10064819B2
(en)
|
2008-05-12 |
2018-09-04 |
University Of Utah Research Foundation |
Intraocular drug delivery device and associated methods
|
|
WO2009142773A2
(en)
|
2008-05-22 |
2009-11-26 |
Bristol-Myers Squibb Company |
Multivalent fibronectin based scaffold domain proteins
|
|
US8617139B2
(en)
|
2008-06-25 |
2013-12-31 |
Transcend Medical, Inc. |
Ocular implant with shape change capabilities
|
|
HRP20141047T1
(hr)
|
2008-08-01 |
2015-01-02 |
Eye Therapies Llc |
Pripravci za sužavanje krvnih žila i metode njihove uporabe
|
|
US12246013B2
(en)
|
2008-08-01 |
2025-03-11 |
Eye Therapies Llc |
Vasoconstriction compositions and methods of use
|
|
US20110190323A1
(en)
*
|
2008-08-28 |
2011-08-04 |
President And Fellows Of Harvard College |
Cortistatin analogues and syntheses thereof
|
|
US20100121441A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Nabil Jabbour |
Surgical implant and method
|
|
US9095506B2
(en)
|
2008-11-17 |
2015-08-04 |
Allergan, Inc. |
Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
|
|
US8034813B2
(en)
*
|
2008-11-18 |
2011-10-11 |
Bausch & Lomb Incorporated |
Polymorphs of brimonidine pamoate
|
|
US9943402B2
(en)
|
2008-11-20 |
2018-04-17 |
Insight Innovations, Llc |
Micropatterned intraocular implant
|
|
US8551167B2
(en)
|
2008-11-20 |
2013-10-08 |
Insight Innovations, Llc |
Intraocular implant cell migration inhibition system
|
|
NZ592645A
(en)
*
|
2008-11-20 |
2013-01-25 |
Insight Innovations Llc |
Biocompatible biodegradable intraocular implant system
|
|
US20120232649A1
(en)
|
2008-11-20 |
2012-09-13 |
Insight Innovations, Llc |
Intraocular Lens Cell Migration Inhibition System
|
|
TWI496582B
(zh)
|
2008-11-24 |
2015-08-21 |
必治妥美雅史谷比公司 |
雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子
|
|
US20100158980A1
(en)
|
2008-12-18 |
2010-06-24 |
Casey Kopczynski |
Drug delivery devices for delivery of therapeutic agents
|
|
US8545554B2
(en)
*
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
|
US20100191177A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Iscience Interventional Corporation |
Device for aspirating fluids
|
|
US8425473B2
(en)
|
2009-01-23 |
2013-04-23 |
Iscience Interventional Corporation |
Subretinal access device
|
|
EP3735947B1
(de)
|
2009-01-28 |
2022-05-04 |
Alcon Inc. |
System zum einbringen eines augenimplantats
|
|
AU2010208046B2
(en)
|
2009-01-29 |
2014-10-02 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
US9636255B2
(en)
|
2009-02-13 |
2017-05-02 |
Dose Medical Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
WO2010096561A1
(en)
|
2009-02-18 |
2010-08-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Synthetic hiv/siv gag proteins and uses thereof
|
|
JP5342301B2
(ja)
*
|
2009-03-30 |
2013-11-13 |
三菱重工業株式会社 |
太陽光集光受熱器
|
|
US8632511B2
(en)
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
|
USD629503S1
(en)
|
2009-05-08 |
2010-12-21 |
Sean Caffey |
Implantable drug-delivery pump
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
EP2432420A4
(de)
|
2009-05-18 |
2018-01-10 |
Dose Medical Corporation |
Arzneimittelfreisetzendes augenimplantat
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
EP2437684B1
(de)
|
2009-06-03 |
2022-06-15 |
ForSight Vision5, Inc. |
Wirkstofffreisetzung im vorderen augensegment
|
|
IN2012DN00352A
(de)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
WO2010148352A1
(en)
|
2009-06-19 |
2010-12-23 |
Altos Vision Limited |
Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
|
|
JP5758388B2
(ja)
|
2009-08-18 |
2015-08-05 |
ミニパンプス， エルエルシー |
適応制御を有する電解質薬物送達ポンプ
|
|
US9605844B2
(en)
*
|
2009-09-01 |
2017-03-28 |
Cree, Inc. |
Lighting device with heat dissipation elements
|
|
WO2011038236A2
(en)
|
2009-09-25 |
2011-03-31 |
Ortho Kinematics, Inc. |
Systems and devices for an integrated imaging system with real-time feedback loops and methods therefor
|
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
|
US20120219583A1
(en)
|
2009-10-16 |
2012-08-30 |
Los Alamos National Security, Llc |
Nucleic acid sequences encoding expandable hiv mosaic proteins
|
|
CA2779104C
(en)
*
|
2009-10-30 |
2018-07-17 |
Aton Pharma, Inc. |
Ocular drug delivery devices
|
|
WO2011057254A2
(en)
|
2009-11-09 |
2011-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Simian adenoviral vector-based vaccines
|
|
DK2498783T3
(en)
|
2009-11-09 |
2018-12-10 |
Allergan Inc |
COMPOSITIONS AND PROCEDURES FOR STIMULATING HAIR GROWTH
|
|
WO2011060215A1
(en)
|
2009-11-13 |
2011-05-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
|
|
US8177747B2
(en)
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
|
US8529492B2
(en)
|
2009-12-23 |
2013-09-10 |
Trascend Medical, Inc. |
Drug delivery devices and methods
|
|
WO2011079232A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Psivida Us, Inc. |
Sustained release delivery devices
|
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
EP3263574B1
(de)
|
2010-02-23 |
2019-04-03 |
PowerVision, Inc. |
Akkomodative intraokularlinse
|
|
WO2011106697A1
(en)
|
2010-02-25 |
2011-09-01 |
Schepens Eye Research Institute |
Therapeutic compositions for the treatment of dry eye disease
|
|
EP2547362B1
(de)
|
2010-03-17 |
2021-08-25 |
Cornell University |
Unterbrochener impfstoff auf adenovirusbasis gegen drogenmissbrauch
|
|
WO2011116336A1
(en)
|
2010-03-19 |
2011-09-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxyl (hno) releasing compounds and uses thereof in treating diseases
|
|
WO2011133964A2
(en)
|
2010-04-23 |
2011-10-27 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
|
MX340696B
(es)
|
2010-04-30 |
2016-07-21 |
Alexion Pharma Inc |
Anticuerpos anti-c5a y metodos para usar los anticuerpos.
|
|
EP2383286A1
(de)
|
2010-04-30 |
2011-11-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren und Zusammensetzungen zur Behandlung von degenerativen Netzhauterkrankungen
|
|
EP2571526B1
(de)
*
|
2010-05-17 |
2019-03-13 |
Novaer Holdings, Inc. |
Wirkstofffreisetzungsvorrichtungen zur freisetzung okularer therapeutischer wirkstoffe
|
|
JP6023703B2
(ja)
|
2010-05-26 |
2016-11-09 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
改善された安定性を有するフィブロネクチンをベースとする足場タンパク質
|
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
|
CN103209664A
(zh)
*
|
2010-08-05 |
2013-07-17 |
弗赛特影像4股份有限公司 |
可植入的治疗装置
|
|
EP3861969A1
(de)
|
2010-08-05 |
2021-08-11 |
ForSight Vision4, Inc. |
Injektorvorrichtung zur arzneimittelabgabe
|
|
WO2012021730A2
(en)
|
2010-08-11 |
2012-02-16 |
Genvec, Inc. |
Respiratory syncytial virus (rsv) vaccine
|
|
JP5996544B2
(ja)
|
2010-10-15 |
2016-09-21 |
クリアサイド・バイオメディカル・インコーポレーテッドＣｌｅａｒｓｉｄｅ Ｂｉｏｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ |
眼球アクセス用装置
|
|
WO2012061045A2
(en)
|
2010-11-01 |
2012-05-10 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving retinal ganglion cells
|
|
US20160256320A1
(en)
|
2010-11-15 |
2016-09-08 |
Aquesys, Inc. |
Intraocular shunt placement in the suprachoroidal space
|
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
EP2654715B1
(de)
|
2010-11-24 |
2017-01-25 |
Dose Medical Corporation |
Arzneimittelfreisetzendes augenimplantat
|
|
EP3150113A1
(de)
|
2010-12-13 |
2017-04-05 |
Ortho Kinematics, Inc. |
Verfahren, systeme und vorrichtungen zur berichterstattung über klinische daten und für chirurgische navigation
|
|
WO2012083297A2
(en)
|
2010-12-17 |
2012-06-21 |
Genvec, Inc. |
Adenoviral vectors with modified hexon regions
|
|
WO2012088041A1
(en)
|
2010-12-20 |
2012-06-28 |
Genvec, Inc. |
Adenoviral vector-based dengue fever vaccine
|
|
WO2012114138A1
(fr)
|
2011-02-21 |
2012-08-30 |
Cerebel-Invest Sa |
Implants biodégradables pour la libération contrôlée sous-conjonctivale d'une molécule active
|
|
WO2012118796A1
(en)
|
2011-02-28 |
2012-09-07 |
The Schepens Eye Research Institute, Inc. |
Compositions for controlling neuronal outgrowth
|
|
US10286146B2
(en)
|
2011-03-14 |
2019-05-14 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
US9919099B2
(en)
|
2011-03-14 |
2018-03-20 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
US9603997B2
(en)
|
2011-03-14 |
2017-03-28 |
Minipumps, Llc |
Implantable drug pumps and refill devices therefor
|
|
WO2012131583A2
(en)
*
|
2011-03-27 |
2012-10-04 |
Microsert Ltd. |
Miniature implanted drug delivery devices and inserter systems for introducing such devices
|
|
US9012647B2
(en)
|
2011-04-07 |
2015-04-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nitroxide modified non-steroidal anti-inflammatory compounds and uses thereof in the treatment and prevention of diseases or disorders
|
|
US8889672B2
(en)
|
2011-04-29 |
2014-11-18 |
The Regents Of The University Of Michigan |
Compounds, formulations, and methods of protein kinase C inhibition
|
|
WO2012162428A1
(en)
|
2011-05-23 |
2012-11-29 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Prime-boost vaccination for viral infection
|
|
DK3354665T5
(da)
|
2011-06-02 |
2022-09-19 |
Massachusetts Inst Technology |
Modificerede alginater til celleindkapsling og celleterapi
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
US9133082B2
(en)
|
2011-06-14 |
2015-09-15 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
WO2013003467A2
(en)
|
2011-06-27 |
2013-01-03 |
Massachusetts Eye And Ear Infirmary |
Methods for treating ocular inflammatory disorders
|
|
US10398592B2
(en)
|
2011-06-28 |
2019-09-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
WO2013025840A1
(en)
|
2011-08-15 |
2013-02-21 |
Massachusetts Eye And Ear Infirmary |
Methods for preserving photoreceptor cell viability following retinal detachment
|
|
US11363951B2
(en)
|
2011-09-13 |
2022-06-21 |
Glaukos Corporation |
Intraocular physiological sensor
|
|
JP5989780B2
(ja)
|
2011-09-14 |
2016-09-07 |
フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． |
眼挿入装置および方法
|
|
PT2755600T
(pt)
|
2011-09-16 |
2021-04-19 |
Forsight Vision4 Inc |
Aparelhos de troca de fluidos
|
|
CA2849192C
(en)
|
2011-10-12 |
2019-09-24 |
Ascendis Pharma Ophthalmology Division A/S |
Prevention and treatment of ocular conditions
|
|
CA2856703A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
EP2773341A2
(de)
|
2011-10-21 |
2014-09-10 |
Massachusetts Eye & Ear Infirmary |
Zusammensetzungen mit nekroseinhibitoren wie necrostatinen, allein oder in kombination, zur förderung der axonregeneration und nervenfunktion zur behandlung von zns-erkrankungen
|
|
WO2013082000A1
(en)
|
2011-11-30 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
AU2012346537A1
(en)
|
2011-12-01 |
2014-07-17 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
US8765210B2
(en)
|
2011-12-08 |
2014-07-01 |
Aquesys, Inc. |
Systems and methods for making gelatin shunts
|
|
US10080682B2
(en)
|
2011-12-08 |
2018-09-25 |
Aquesys, Inc. |
Intrascleral shunt placement
|
|
US9808373B2
(en)
|
2013-06-28 |
2017-11-07 |
Aquesys, Inc. |
Intraocular shunt implantation
|
|
US8852136B2
(en)
|
2011-12-08 |
2014-10-07 |
Aquesys, Inc. |
Methods for placing a shunt into the intra-scleral space
|
|
US9610195B2
(en)
|
2013-02-27 |
2017-04-04 |
Aquesys, Inc. |
Intraocular shunt implantation methods and devices
|
|
US9241829B2
(en)
|
2011-12-20 |
2016-01-26 |
Abbott Medical Optics Inc. |
Implantable intraocular drug delivery apparatus, system and method
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
WO2013124477A1
(en)
|
2012-02-24 |
2013-08-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for treatment of retinal degenerative diseases
|
|
US10093947B2
(en)
|
2012-02-28 |
2018-10-09 |
Cornell University |
AAV-directed persistent expression of an anti-nicotine antibody gene for smoking cessation
|
|
US10004811B2
(en)
|
2012-04-13 |
2018-06-26 |
Cornell University |
Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction
|
|
US10085633B2
(en)
|
2012-04-19 |
2018-10-02 |
Novartis Ag |
Direct visualization system for glaucoma treatment
|
|
US9241832B2
(en)
|
2012-04-24 |
2016-01-26 |
Transcend Medical, Inc. |
Delivery system for ocular implant
|
|
HK1210475A1
(en)
|
2012-05-29 |
2016-04-22 |
Genvec, Inc. |
Herpes simplex virus vaccine
|
|
MX351261B
(es)
|
2012-06-01 |
2017-10-06 |
Surmodics Inc |
Aparato y método para recubrir catéteres con globo.
|
|
US9827401B2
(en)
|
2012-06-01 |
2017-11-28 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
WO2013183058A2
(en)
|
2012-06-07 |
2013-12-12 |
Tulip Medical Ltd. |
Expanded device
|
|
EP2895123B1
(de)
|
2012-09-17 |
2017-06-07 |
Novartis Ag |
Expandierende augenimplantatvorrichtungen
|
|
RU2676102C2
(ru)
|
2012-09-27 |
2018-12-26 |
Аллерган, Инк. |
Биодеградируемые системы доставки лекарственных средств для долговременного высвобождения белков
|
|
RU2652063C2
(ru)
|
2012-10-26 |
2018-04-24 |
Форсайт Вижн5, Инк. |
Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу
|
|
MX373894B
(es)
|
2012-11-08 |
2020-07-09 |
Clearside Biomedical Inc |
Métodos y dispositivos para el tratamiento de trastornos oculares en sujetos humanos.
|
|
US9763829B2
(en)
|
2012-11-14 |
2017-09-19 |
Novartis Ag |
Flow promoting ocular implant
|
|
MX366404B
(es)
|
2012-11-15 |
2019-07-08 |
Apellis Pharmaceuticals Inc |
Analogos de compstatina de celula reactiva, de acción prolongada u objetivos y composiciones y metodos relacionados.
|
|
WO2014093270A1
(en)
|
2012-12-10 |
2014-06-19 |
Virginia Commonwealth University |
Tropism modified cancer terminator virus (ad.5/3 ctv;ad.5/3-ctv-m7)
|
|
WO2014124458A1
(en)
|
2013-02-11 |
2014-08-14 |
The Regents Of The University Of California |
Compositions and methods for treating neurodegenerative diseases
|
|
EP2956096A1
(de)
|
2013-02-15 |
2015-12-23 |
Allergan, Inc. |
Implantat mit langzeit-wirkstofffreisetzung
|
|
RS60026B1
(sr)
|
2013-02-18 |
2020-04-30 |
Vegenics Pty Ltd |
Molekuli koji vezuju ligande i njihove upotrebe
|
|
US9125723B2
(en)
|
2013-02-19 |
2015-09-08 |
Aquesys, Inc. |
Adjustable glaucoma implant
|
|
US10159600B2
(en)
|
2013-02-19 |
2018-12-25 |
Aquesys, Inc. |
Adjustable intraocular flow regulation
|
|
WO2014164703A1
(en)
|
2013-03-11 |
2014-10-09 |
University Of Florida Research Foundation, Inc. |
Delivery of card protein as therapy for occular inflammation
|
|
WO2014164704A2
(en)
|
2013-03-11 |
2014-10-09 |
The Broad Institute, Inc. |
Compounds and compositions for the treatment of cancer
|
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
|
WO2014152959A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
EP2967842B1
(de)
|
2013-03-15 |
2020-11-04 |
Alcon Inc. |
Verfahren zum rekonfigurieren einer intraokularlinse zur abgabe an eine abgabevorrichtung
|
|
WO2014152391A1
(en)
|
2013-03-15 |
2014-09-25 |
Apellis Pharmaceuticals, Inc. |
Cell-penetrating compstatin analogs and uses thereof
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
|
CN105246438B
(zh)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
用于输送治疗物质的眼科植入物
|
|
US9987163B2
(en)
|
2013-04-16 |
2018-06-05 |
Novartis Ag |
Device for dispensing intraocular substances
|
|
WO2014179568A2
(en)
|
2013-05-02 |
2014-11-06 |
Odin Biotech |
Two-layer ocular implant
|
|
BR112015027762A2
(pt)
|
2013-05-03 |
2017-08-29 |
Clearside Biomedical Inc |
Aparelho e métodos para injeção ocular
|
|
EP2994758B1
(de)
|
2013-05-08 |
2017-12-20 |
Opthea Limited |
Biomarker für altersbedingte makuladegeneration (amd)
|
|
WO2015035190A1
(en)
|
2013-09-05 |
2015-03-12 |
Cornell University |
Gene therapy for alzheimer's and other neurodegenerative diseases and conditions
|
|
PT3062775T
(pt)
|
2013-10-31 |
2018-03-06 |
Allergan Inc |
Implantes intraoculares contendo prostamida e métodos para a sua utilização
|
|
US10087224B2
(en)
|
2013-11-01 |
2018-10-02 |
Cornell University |
Gene therapy for Alzheimer's and other neurodegenerative diseases and conditions
|
|
CN106459995B
(zh)
|
2013-11-07 |
2020-02-21 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
EP3068372B1
(de)
|
2013-11-14 |
2019-05-08 |
EyeD Pharma |
Augenvorrichtung
|
|
RU2648229C1
(ru)
|
2013-11-14 |
2018-03-22 |
Эквисис, Инк. |
Устройство для введения интраокулярного шунта
|
|
EP3091962B1
(de)
|
2013-12-05 |
2022-06-08 |
Epitomee Medical Ltd. |
Rückhaltevorrichtungen und systeme zur in-situ-freisetzung von pharmazeutischen wirkstoffen
|
|
US10010447B2
(en)
|
2013-12-18 |
2018-07-03 |
Novartis Ag |
Systems and methods for subretinal delivery of therapeutic agents
|
|
AU2014369834B2
(en)
|
2013-12-24 |
2018-12-20 |
President And Fellows Of Harvard College |
Cortistatin analogues and syntheses and uses thereof
|
|
WO2015103480A1
(en)
|
2014-01-02 |
2015-07-09 |
Massachusetts Eye & Ear Infirmary |
Treating ocular neovascularization
|
|
WO2015112739A1
(en)
|
2014-01-22 |
2015-07-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds and method for treating parp1-deficient cancers
|
|
ES2919024T3
(es)
|
2014-02-11 |
2022-07-21 |
Mitokinin Inc |
Composiciones y procedimientos que utilizan las mismas para el tratamiento de enfermedades neurodegenerativas y mitocondriales
|
|
US11028388B2
(en)
|
2014-03-05 |
2021-06-08 |
Editas Medicine, Inc. |
CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa
|
|
NZ631007A
(en)
|
2014-03-07 |
2015-10-30 |
Alexion Pharma Inc |
Anti-c5 antibodies having improved pharmacokinetics
|
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
ES2745769T3
(es)
|
2014-03-10 |
2020-03-03 |
Editas Medicine Inc |
Procedimientos y composiciones relacionados con CRISPR/CAS para tratar la amaurosis congénita de Leber 10 (LCA10)
|
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
EP3540061A1
(de)
|
2014-04-02 |
2019-09-18 |
Editas Medicine, Inc. |
Verfahren und zusammensetzungen in zusammenhang mit crispr/cas zur behandlung eines primären offenwinkelglaukoms
|
|
AU2015266850B2
(en)
|
2014-05-29 |
2019-12-05 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
ES2803102T3
(es)
|
2014-07-15 |
2021-01-22 |
Forsight Vision4 Inc |
Dispositivo de administración de implante ocular
|
|
KR102719485B1
(ko)
|
2014-08-01 |
2024-10-21 |
메사추세츠 인스티튜트 오브 테크놀로지 |
항-섬유 물질 및 응용을 위한 변형된 알기네이트
|
|
RU2017105844A
(ru)
|
2014-08-08 |
2018-09-11 |
Форсайт Вижн4, Инк. |
Стабильные и растворимые составы ингибиторов рецепторных тирозинкиназ и способы их получения
|
|
CN110478119B
(zh)
|
2014-11-10 |
2022-04-15 |
弗赛特影像4股份有限公司 |
可膨胀药物递送装置和使用方法
|
|
FR3028410A1
(fr)
|
2014-11-18 |
2016-05-20 |
Pierre Coulon |
Implant capsulaire multifonctionnel
|
|
CN107635584B
(zh)
|
2015-04-09 |
2022-06-17 |
康奈尔大学 |
基因治疗以预防对过敏原的反应
|
|
US20160296532A1
(en)
|
2015-04-13 |
2016-10-13 |
Forsight Vision5, Inc. |
Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
|
|
WO2016182932A1
(en)
|
2015-05-08 |
2016-11-17 |
President And Fellows Of Harvard College |
Cortistatin analogues, syntheses, and uses thereof
|
|
JP6805174B2
(ja)
|
2015-05-12 |
2020-12-23 |
アメリカ合衆国 |
神経成長因子シグナルペプチド及び副甲状腺ホルモンを含むａａｖ分離株及び融合タンパク質
|
|
US10214731B2
(en)
|
2015-05-28 |
2019-02-26 |
Cornell University |
Adeno-associated virus mediated delivery of C1E1 as a therapy for angioedema
|
|
CA3193470A1
(en)
|
2015-06-03 |
2016-12-08 |
Aquesys, Inc. |
Ab externo intraocular shunt placement
|
|
US20160354161A1
(en)
|
2015-06-05 |
2016-12-08 |
Ortho Kinematics, Inc. |
Methods for data processing for intra-operative navigation systems
|
|
JP6839100B2
(ja)
|
2015-06-10 |
2021-03-03 |
アルコン インコーポレイティド |
眼内レンズ材料及び部材
|
|
EP3316889A4
(de)
|
2015-07-01 |
2018-11-14 |
President and Fellows of Harvard College |
Cortistatin-analoga sowie synthese und verwendungen davon
|
|
RS63319B1
(sr)
|
2015-09-02 |
2022-07-29 |
Trevena Inc |
Jedinjenja koja modulišu delta-opioidni receptor, koja sadrže 6-člani aza-heterociklik, postupci njihove upotrebe i spravljanja
|
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
|
US10182939B2
(en)
|
2015-09-16 |
2019-01-22 |
Novartis Ag |
Hydraulic injector and methods for intra-ocular lens insertion
|
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
|
US11903994B2
(en)
|
2015-10-07 |
2024-02-20 |
Apellis Pharmaceuticals, Inc. |
Dosing regimens
|
|
CN115491373A
(zh)
|
2015-10-30 |
2022-12-20 |
爱迪塔斯医药公司 |
治疗单纯疱疹病毒的crispr/cas相关方法及组合物
|
|
AU2016344041B2
(en)
*
|
2015-11-01 |
2019-11-07 |
Massachusetts Institute Of Technology |
Materials with improved properties
|
|
NZ742800A
(en)
|
2015-11-01 |
2019-03-29 |
Massachusetts Inst Technology |
Modified alginates for anti-fibrotic materials and applications
|
|
US11180538B2
(en)
|
2015-11-13 |
2021-11-23 |
University Of Utah Research Foundation |
Combinatorial gene construct and non-viral delivery for anti-obesity
|
|
WO2017087902A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
|
US10390901B2
(en)
|
2016-02-10 |
2019-08-27 |
Clearside Biomedical, Inc. |
Ocular injection kit, packaging, and methods of use
|
|
CN109475756A
(zh)
|
2016-02-17 |
2019-03-15 |
儿童医疗中心有限公司 |
Ffa1(gpr40)作为神经血管生成疾病或病症的治疗标靶
|
|
WO2017173327A1
(en)
|
2016-03-31 |
2017-10-05 |
The Schepens Eye Research Institute, Inc. |
Endomucin inhibitor as an anti-angiogenic agent
|
|
CN113017981B
(zh)
|
2016-04-05 |
2023-07-25 |
弗赛特影像4股份有限公司 |
药物递送装置
|
|
AU2017252294B2
(en)
|
2016-04-20 |
2021-12-02 |
Glaukos Corporation |
Bioresorbable ocular drug delivery device
|
|
EP3452165A1
(de)
|
2016-05-02 |
2019-03-13 |
Clearside Biomedical, Inc. |
Systeme und verfahren zur verabreichung eines augenmedikaments
|
|
US10501744B2
(en)
|
2016-05-04 |
2019-12-10 |
Indiana University Research And Technology Corporation |
Presentation of bioactive proteins
|
|
CA3024618A1
(en)
|
2016-05-27 |
2017-11-30 |
Alexion Pharmaceuticals, Inc. |
Methods for treatment of refractory generalized myasthenia gravis
|
|
CN109561987A
(zh)
|
2016-06-02 |
2019-04-02 |
阿奎西斯公司 |
眼内药物递送
|
|
CA3027200A1
(en)
|
2016-06-13 |
2017-12-21 |
Massachusetts Institute Of Technology |
Biocompatible zwitterionic polymer coatings and hydrogels for reducing foreign body response and fibrosis
|
|
BR112019001887A2
(pt)
|
2016-08-02 |
2019-07-09 |
Editas Medicine Inc |
composições e métodos para o tratamento de doença associada a cep290
|
|
IL305537B2
(en)
|
2016-08-12 |
2025-02-01 |
Clearside Biomedical Inc |
Devices and methods for adjusting the insertion depth of a needle for administering a drug
|
|
AU2017312499B2
(en)
|
2016-08-19 |
2023-02-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
|
|
WO2018081504A1
(en)
|
2016-10-28 |
2018-05-03 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating herpes simplex virus
|
|
EP4520828A3
(de)
|
2016-11-15 |
2025-07-09 |
The Schepens Eye Research Institute, Inc. |
Zusammensetzungen und verfahren zur behandlung von aberranter angiogenese
|
|
AU2017387141A1
(en)
*
|
2016-12-29 |
2019-07-18 |
Pure Ratios Holdings, Inc. |
Modular transdermal delivery system and associated methods of manufacture and use
|
|
AU2018221148B2
(en)
|
2017-02-17 |
2022-05-05 |
Trevena, Inc. |
5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
|
|
CN110446495B
(zh)
|
2017-02-17 |
2023-09-05 |
特维娜有限公司 |
含有7元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
|
|
EP3600345A4
(de)
|
2017-03-29 |
2021-01-06 |
Cornell University |
Oxidationsresistente aat-gentherapie
|
|
IL269844B2
(en)
|
2017-04-07 |
2025-01-01 |
Apellis Pharmaceuticals Inc |
Dosage regimens and related compositions and methods
|
|
US12090294B2
(en)
|
2017-05-02 |
2024-09-17 |
Georgia Tech Research Corporation |
Targeted drug delivery methods using a microneedle
|
|
KR102872720B1
(ko)
|
2017-05-05 |
2025-10-16 |
유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
기질 결합 소낭의 안구에의 적용
|
|
US20200147055A1
(en)
*
|
2017-05-30 |
2020-05-14 |
Eximore Ltd. |
Compositions and methods for treating dry eye syndrome delivering antibiotic macrolide
|
|
AU2018290225A1
(en)
|
2017-06-21 |
2020-01-23 |
Mitokinin, Inc. |
Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
|
|
CN111133006A
(zh)
|
2017-07-14 |
2020-05-08 |
西托姆克斯治疗公司 |
抗cd166抗体及其用途
|
|
DK3658184T5
(da)
|
2017-07-27 |
2024-08-26 |
Alexion Pharma Inc |
Højkoncentrerede anti-c5-antistofformuleringer
|
|
WO2019033119A1
(en)
|
2017-08-11 |
2019-02-14 |
Unity Biotechnology, Inc. |
TREATMENT OF OPHTHALMIC CONDITIONS SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLS
|
|
US12025615B2
(en)
|
2017-09-15 |
2024-07-02 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods of classifying response to immunotherapy for cancer
|
|
BR112020006601A2
(pt)
|
2017-10-02 |
2020-12-08 |
Genedit Inc. |
Rna guia de cpf1 modificado
|
|
WO2019070917A1
(en)
|
2017-10-03 |
2019-04-11 |
The Schepens Eye Research Institute, Inc. |
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE DEGENERATION OF RETINAL PIGMENT EPITHELIUM AND METHODS USING SAME
|
|
EP3697401B1
(de)
|
2017-10-18 |
2025-12-03 |
Washington University |
Dominante negative sarm1-moleküle als therapeutische strategie für neurodegenerative erkrankungen oder störungen
|
|
CN118512588A
(zh)
|
2017-10-26 |
2024-08-20 |
亚力兄制药公司 |
用于治疗阵发性夜间性血红蛋白尿(pnh)和非典型溶血性尿毒症综合征(ahus)的抗c5抗体的剂量和施用
|
|
US11318231B2
(en)
|
2017-11-06 |
2022-05-03 |
Massachusetts Institute Of Technology |
Anti-inflammatory coatings to improve biocompatibility of neurological implants
|
|
US11246753B2
(en)
|
2017-11-08 |
2022-02-15 |
Aquesys, Inc. |
Manually adjustable intraocular flow regulation
|
|
US11739326B2
(en)
|
2017-11-14 |
2023-08-29 |
Massachusetts Eye And Ear Infirmary |
RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
|
|
CN111655206B
(zh)
|
2017-11-21 |
2022-10-14 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
|
WO2019118938A1
(en)
|
2017-12-15 |
2019-06-20 |
Apellis Pharmaceuticals, Inc. |
Dosing regimens and related compositions and methods
|
|
KR20240132386A
(ko)
|
2017-12-29 |
2024-09-03 |
코넬 유니버시티 |
호산구성 장애에 대한 유전자 요법
|
|
US12305185B2
(en)
|
2018-01-23 |
2025-05-20 |
Mount Spec Investments Pty Ltd |
Expression vector and method
|
|
WO2019161378A1
(en)
|
2018-02-19 |
2019-08-22 |
University Of Miami |
Cyclophosphamide for treating ophthalmic inflammation
|
|
EP3758736B1
(de)
|
2018-03-02 |
2024-05-01 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Il-34 zur anwendung in einem verfahren zur behandlung von retinaler entzündung und neurodegeneration
|
|
US10952898B2
(en)
|
2018-03-09 |
2021-03-23 |
Aquesys, Inc. |
Intraocular shunt inserter
|
|
US11135089B2
(en)
|
2018-03-09 |
2021-10-05 |
Aquesys, Inc. |
Intraocular shunt inserter
|
|
DE102018106217A1
(de)
|
2018-03-16 |
2019-09-19 |
Amw Gmbh |
Applikator
|
|
CA3095911A1
(en)
|
2018-04-03 |
2019-10-10 |
Cornell University |
Gene therapy for oxidative stress
|
|
US11821009B2
(en)
|
2018-05-15 |
2023-11-21 |
Cornell University |
Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector delivery
|
|
EP3802593B1
(de)
|
2018-05-31 |
2024-09-11 |
Alexion Pharmaceuticals, Inc. |
Dosierung und verabreichung von anti-c5 antikörpern zur behandlung von paroxysalen nocturalen hämoglobin-uria (pnh) in pädiatrischen patienten
|
|
EP3802603A1
(de)
|
2018-06-04 |
2021-04-14 |
Alexion Pharmaceuticals, Inc. |
Dosierung und verabreichung von anti-c5-antikörpern zur behandlung des atypischen hämolytisch-urämischen syndroms (ahus) bei kindern
|
|
US12312394B2
(en)
|
2018-06-28 |
2025-05-27 |
Alexion Pharmaceuticals, Inc. |
Methods of producing anti-C5 antibodies
|
|
KR20210052450A
(ko)
|
2018-07-31 |
2021-05-10 |
코넬 유니버시티 |
기관 기능을 제어하기 위한 유전자 요법 방법
|
|
EP3873602B1
(de)
|
2018-10-30 |
2023-12-06 |
Alexion Pharmaceuticals, Inc. |
Subcutane dosierung und ztudienung von anti-c5-antikörpern zur behandlung der paroxysmalen nicht-turnalen hämoglobinurie (pnh)
|
|
WO2020112816A1
(en)
|
2018-11-29 |
2020-06-04 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
AU2019397033B2
(en)
|
2018-12-12 |
2023-06-29 |
Kite Pharma, Inc. |
Chimeric antigen receptors and CAR-T cells and methods of use
|
|
CA3130515A1
(en)
|
2019-02-25 |
2020-09-03 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
|
|
US11819590B2
(en)
|
2019-05-13 |
2023-11-21 |
Surmodics, Inc. |
Apparatus and methods for coating medical devices
|
|
AU2020302924A1
(en)
|
2019-06-27 |
2022-02-17 |
Layerbio, Inc. |
Ocular device delivery methods and systems
|
|
EP4007609A1
(de)
|
2019-08-01 |
2022-06-08 |
Cornell University |
Gezielte gentherapie zur behandlung von neurologischen erkrankungen
|
|
WO2021062012A1
(en)
|
2019-09-25 |
2021-04-01 |
Emory University |
Use of klk10 and engineered derivatizations thereof
|
|
WO2021067550A1
(en)
|
2019-10-02 |
2021-04-08 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions for identifying neoantigens for use in treating and preventing cancer
|
|
JP2022552375A
(ja)
|
2019-10-15 |
2022-12-15 |
コーネル・ユニバーシティー |
遺伝子治療発現カセットからの発現レベルを調節するための方法
|
|
US11471426B2
(en)
|
2019-10-16 |
2022-10-18 |
American River Nutrition, Llc |
Compositions comprising quinone and/or quinol and methods of preparations and use thereof
|
|
JP2023500793A
(ja)
|
2019-10-16 |
2023-01-11 |
コーネル・ユニバーシティー |
アルツハイマー病に対する遺伝子治療方法
|
|
WO2021086973A2
(en)
|
2019-10-28 |
2021-05-06 |
University Of Iowa Research Foundation |
Formulation for delivery of lubricin gene
|
|
EP4065600A1
(de)
|
2019-11-25 |
2022-10-05 |
Cornell University |
Apoe-gentherapie
|
|
JP7703543B2
(ja)
|
2020-01-17 |
2025-07-07 |
ザ ユナイテッド ステイツ オブ アメリカ アズ リプリゼンテッド バイ ザ セクレタリー、デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
Ｃｒｘ常染色体優性網膜症の処置のための遺伝子治療
|
|
AU2021225926A1
(en)
|
2020-02-26 |
2022-10-20 |
Case Western Reserve University |
Compositions and methods for treating misfolded protein ocular disorders
|
|
WO2021188804A1
(en)
|
2020-03-20 |
2021-09-23 |
Athanor Biosciences, Inc. |
Bacteriophage-based vaccines and engineered bacteriophage
|
|
CA3179541A1
(en)
|
2020-04-05 |
2021-10-14 |
Athanor Biosciences, Inc. |
Bacteriophage-based antibodies and protein-based binders
|
|
EP4138921A1
(de)
|
2020-04-23 |
2023-03-01 |
University Of Iowa Research Foundation |
Proteolytische gegen gp gerichtete chimären
|
|
KR20230005268A
(ko)
|
2020-04-24 |
2023-01-09 |
밀레니엄 파머슈티컬스 인코퍼레이티드 |
항-cd19 항체 및 이의 용도
|
|
JP7579594B2
(ja)
|
2020-05-15 |
2024-11-08 |
アイフロー・インコーポレーテッド |
哺乳類の眼の従来の房水排出路内の移植物のための方法及び装置
|
|
US20230301984A1
(en)
|
2020-07-02 |
2023-09-28 |
The Usa, As Represented By The Secretary, Department Of Health And Human Services |
Cyclic compounds for use in treating retinal degeneration
|
|
WO2022011099A1
(en)
|
2020-07-08 |
2022-01-13 |
Regents Of The University Of Minnesota |
Modified hexosaminidase and uses thereof
|
|
WO2022036104A1
(en)
|
2020-08-12 |
2022-02-17 |
University Of Iowa Research Foundation |
Insulin sensitizers for the treatment of diabetes mellitus
|
|
WO2022040564A1
(en)
|
2020-08-21 |
2022-02-24 |
University Of Iowa Research Foundation |
Cationic nanoparticle adjuvants
|
|
WO2022047201A1
(en)
|
2020-08-27 |
2022-03-03 |
University Of Iowa Research Foundation |
Gene knock-out for treatment of glaucoma
|
|
WO2022125963A1
(en)
|
2020-12-11 |
2022-06-16 |
University Of Iowa Research Foundation |
Compositions comprising molecules for cystic fibrosis treatment
|
|
US12496612B2
(en)
|
2021-01-08 |
2025-12-16 |
Surmodics, Inc. |
Coating application system and methods for coating rotatable medical devices
|
|
WO2022215054A1
(en)
|
2021-04-09 |
2022-10-13 |
Takeda Pharmaceutical Company Limited |
Antibodies targeting complement factor d and uses therof
|
|
WO2022221741A1
(en)
|
2021-04-16 |
2022-10-20 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
|
|
MX2023011712A
(es)
|
2021-04-26 |
2023-10-12 |
Millennium Pharm Inc |
Anticuerpos anti receptor de adhesion acoplado a proteinas g e2 (adgre2) y usos de los mismos.
|
|
CA3216770A1
(en)
|
2021-04-26 |
2022-11-03 |
Tomoki Yoshihara |
Anti-clec12a antibodies and uses thereof
|
|
US20240238383A1
(en)
|
2021-05-21 |
2024-07-18 |
University Of Lowa Research Foundation |
Anti-oxidant containing particles and methods of use
|
|
US20240293322A1
(en)
|
2021-06-23 |
2024-09-05 |
University Of Iowa Research Foundation |
Sustained release formulations comprising a selective androgen receptor modulator
|
|
WO2023283281A1
(en)
|
2021-07-07 |
2023-01-12 |
Genentech, Inc. |
Rod inserter system and methods
|
|
IL311837A
(en)
|
2021-10-20 |
2024-05-01 |
Takeda Pharmaceuticals Co |
Compositions targeting bcma and methods of use thereof
|
|
US20250049758A1
(en)
|
2021-12-06 |
2025-02-13 |
Breye Therapeutics Aps |
Danegaptide Formulation for Application in the Eye
|
|
US20250073322A1
(en)
|
2021-12-29 |
2025-03-06 |
University Of Lowa Research Foundation |
Cystatin rna compositions for tissue engineering
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
US20250179157A1
(en)
|
2022-02-28 |
2025-06-05 |
University Of Lowa Research Foundation |
A-fabp antibodies for diagnosis and treatment of obesity-associated diseases
|
|
US20230346862A1
(en)
|
2022-05-02 |
2023-11-02 |
Athanor Biosciences, Inc. |
Cancer eradicating - bio-nanoparticles (ce-bnp)
|
|
WO2023215560A1
(en)
|
2022-05-05 |
2023-11-09 |
Atoosa Corporation |
Tumor cell/immune cell multivalent receptor engager – bio-nanoparticle (timre-bnp)
|
|
WO2024196814A1
(en)
|
2023-03-17 |
2024-09-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for treatment of age-related macular degeneration
|
|
WO2024233783A1
(en)
|
2023-05-09 |
2024-11-14 |
Cornell University |
Expression cassette coding for vascular endothelial growth factor
|
|
CN119265241A
(zh)
|
2023-06-30 |
2025-01-07 |
深圳菁童生命科学有限公司 |
一种无相分离转录因子介导启始阶段重编程使细胞年轻化的方法
|
|
WO2025038668A1
(en)
|
2023-08-14 |
2025-02-20 |
Voro Therapeutics, Inc. |
Therapeutic binding agents that conditionally promote myeloid cell activity against target cells and uses thereof
|
|
WO2025083169A1
(en)
|
2023-10-17 |
2025-04-24 |
Tenpoint Therapeutics Limited |
Combination of a vegf inhibitor and a complement pathway inhibitor for treating ocular disorders
|
|
WO2025171234A1
(en)
|
2024-02-07 |
2025-08-14 |
Gensaic, Inc. |
Compositions for targeted delivery to muscle tissue
|
|
WO2025171280A1
(en)
|
2024-02-07 |
2025-08-14 |
Gensaic, Inc. |
Compositions for targeted delivery to adipose tissue
|
|
WO2025213111A2
(en)
|
2024-04-05 |
2025-10-09 |
Cornell University |
Aav expression of mirna to suppress human apoe mrna
|
|
WO2025213138A1
(en)
|
2024-04-05 |
2025-10-09 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma
|